Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,790
Total Claims
$859K
Drug Cost
900
Beneficiaries
$954
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-96%
Opioid rate vs peers
0.1% vs 2.2% avg
-32%
Cost per patient vs peers
$954 vs $1,411 avg
-11%
Brand preference vs peers
9.4% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
11
Opioid Claims
$15
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,104 claims · $728K
Generic: 10,581 claims · $127K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Canagliflozin | 169 | $152K |
| Apixaban | 93 | $111K |
| Rivaroxaban | 65 | $60K |
| Fluticasone/Umeclidin/Vilanter | 58 | $55K |
| Rifaximin | 12 | $41K |
| Insulin Degludec | 43 | $35K |
| Sitagliptin Phosphate | 21 | $26K |
| Insulin Degludec | 24 | $23K |
| Linagliptin | 15 | $23K |
| Mirabegron | 19 | $15K |
| Sacubitril/Valsartan | 19 | $15K |
| Semaglutide | 13 | $13K |
| Ezetimibe | 631 | $10K |
| Rosuvastatin Calcium | 880 | $9,392 |
| Fluticasone/Vilanterol | 16 | $9,330 |
Prescribing Profile
Patient Profile
71
Avg Age
53%
Female
1.58
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data